Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019_ randomised controlled trial Auteur/autrice de la publication :Admin Post published:23 janvier 2021 Post category:COVID 19 Effect-of-tocilizumab-on-clinical-outcomes-at-15-days-in-patients-with-severe-or-critical-coronavirus-disease-2019_-randomised-controlled-trialTélécharger Vous devriez également aimer Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths 27 septembre 2021 Bronchiolitis in COVID-19 times_ a nearly absent disease_ 10 février 2021 Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii 14 décembre 2020
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths 27 septembre 2021
